Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis: a journey of a thousand miles begins with a single (big) step

Bone Marrow Transplantation volume 42, pages 433–437 (2008)Cite this article

Abstract

Hemophagocytic lymphohistiocytosis (HLH) is a rare, highly fatal disorder of uncontrolled inflammation, usually affecting infants. Significant progress in the treatment of this disorder has been achieved during the last decade, and outcomes for larger series of patients have been reported in recent years. Although medical therapy has advanced, hematopoietic cell transplantation remains the only curative therapy for patients with the familial form of this disorder. Unfortunately, these patients have demonstrated relatively poor post-transplant outcomes for a nonmalignant disorder, with approximately 30% mortality in the first 100 days. Early deaths were attributable to infection, GVHD, and unusually high rates of primary nonengraftment, venoocclusive disease and pneumonitis. In addition, a significant number of deaths were due to HLH reactivation, a unique complication seen in this patient group. In contrast, late complications were relatively infrequent and essentially all patients with durable engraftment remained in remission indefinitely. In this review, we will discuss recent progress in the transplant management of patients with HLH and potential future strategies, including the use of reduced intensity conditioning regimens.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Scott R, Robb-Smith A . Histiocytic medullary reticulosis. Lancet 1939; 2: 194–198.

    Article  Google Scholar 

  2. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, Bhawan S, Certain S, Mathew PA et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 1999; 286: 1957–1959.

    Article  CAS  Google Scholar 

  3. Jordan MB, Hildeman D, Kappler J, Marrack P . An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder. Blood 2004; 104: 735–743.

    Article  CAS  PubMed  Google Scholar 

  4. Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48: 124–131.

    Article  PubMed  Google Scholar 

  5. Billiau AD, Roskams T, Van Damme-Lombaerts R, Matthys P, Wouters C . Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-gamma-producing lymphocytes and IL-6- and TNF-alpha-producing macrophages. Blood 2005; 105: 1648–1651.

    Article  CAS  PubMed  Google Scholar 

  6. Henter JI, Elinder G, Soder O, Hansson M, Andersson B, Andersson U . Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 1991; 78: 2918–2922.

    CAS  PubMed  Google Scholar 

  7. Henter JI, Arico M, Elinder G, Imashuku S, Janka G . Familial hemophagocytic lymphohistiocytosis. Primary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am 1998; 12: 417–433.

    Article  CAS  PubMed  Google Scholar 

  8. Clementi R, Emmi L, Maccario R, Liotta F, Moretta L, Danesino C et al. Adult onset and atypical presentation of hemophagocytic lymphohistiocytosis in siblings carrying PRF1 mutations. Blood 2002; 100: 2266–2267.

    Article  CAS  PubMed  Google Scholar 

  9. Santoro A, Cannella S, Bossi G, Gallo F, Trizzino A, Pende D et al. Novel Munc13-4 mutations in children and young adult patients with haemophagocytic lymphohistiocytosis. J Med Genet 2006; 43: 953–960.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Henter JI, Elinder G, Soder O, Ost A . Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis. Acta Paediatr Scand 1991; 80: 428–435.

    Article  CAS  PubMed  Google Scholar 

  11. Janka GE . Familial hemophagocytic lymphohistiocytosis. Eur J Pediatr 1983; 140: 221–230.

    Article  CAS  PubMed  Google Scholar 

  12. Henter JI, Samuelsson-Horne A, Arico M, Egeler RM, Elinder G, Filipovich AH et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 2002; 100: 2367–2373.

    Article  CAS  PubMed  Google Scholar 

  13. Mahlaoui N, Ouachee-Chardin M, de Saint Basile G, Neven B, Picard C, Blanche S et al. Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients. Pediatrics 2007; 120: e622–e628.

    Article  PubMed  Google Scholar 

  14. Horne A, Janka G, Maarten Egeler R, Gadner H, Imashuku S, Ladisch S et al. Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis. Br J Haematol 2005; 129: 622–630.

    Article  PubMed  Google Scholar 

  15. Baker KS, Filipovich AH, Gross TG, Grossman WJ, Hale GA, Hayashi RJ et al. Unrelated donor hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis. Bone Marrow Transplant 2008; 42: 175–180.

    Article  CAS  PubMed  Google Scholar 

  16. Ouachee-Chardin M, Elie C, de Saint Basile G, Le Deist F, Mahlaoui N, Picard C et al. Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis: a single-center report of 48 patients. Pediatrics 2006; 117: e743–e750.

    Article  PubMed  Google Scholar 

  17. Cooper N, Rao K, Gilmour K, Hadad L, Adams S, Cale C et al. Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis. Blood 2006; 107: 1233–1236.

    Article  CAS  PubMed  Google Scholar 

  18. Schaer DJ, Schleiffenbaum B, Kurrer M, Imhof A, Bachli E, Fehr J et al. Soluble hemoglobin–haptoglobin scavenger receptor CD163 as a lineage-specific marker in the reactive hemophagocytic syndrome. Eur J Haematol 2005; 74: 6–10.

    Article  CAS  PubMed  Google Scholar 

  19. Klangsinsirikul P, Carter GI, Byrne JL, Hale G, Russell NH . Campath-1G causes rapid depletion of circulating host dendritic cells (DCs) before allogeneic transplantation but does not delay donor DC reconstitution. Blood 2002; 99: 2586–2591.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Divisions of Immunobiology and Hematology/Oncology/BMT, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH, USA

    M B Jordan & A H Filipovich

Authors
  1. M B Jordan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A H Filipovich
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to M B Jordan or A H Filipovich.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jordan, M., Filipovich, A. Hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis: a journey of a thousand miles begins with a single (big) step. Bone Marrow Transplant 42, 433–437 (2008). https://doi.org/10.1038/bmt.2008.232

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2008.232

Keywords

This article is cited by

Search

Advanced search

Quick links